GlassScriptPhysician profile
Ranjit Singh Banwait
NPI 1306341144
$2,203.79
in general payments reported to CMS, 2019-2025
17 companies · $684 in 2025
The $684 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $499 · 2024: $792 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Education: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.38 |
| Education | $398.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $627.66 | 2023-2025 | Lynparza, Calquence, Enhertu |
| Seagen INC. | $433.81 | 2022-2024 | Tukysa |
| Daiichi Sankyo INC. | $237.06 | 2022-2025 | Enhertu |
| Incyte Corporation | $207.26 | 2024-2025 | Jakafi, Niktimvo |
| Gilead Sciences, INC. | $124.99 | 2024 | Trodelvy |
| Kyowa Kirin, INC. | $101.00 | 2025 | |
| Sobi, INC | $99.99 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.12 | 2025 | Alunbrig, Fruzaqla |
| Jazz Pharmaceuticals INC. | $58.57 | 2024 | |
| Lilly USA, LLC | $48.90 | 2024 | Jaypirca |
| Aveo Pharmaceuticals, INC. | $43.08 | 2025 | |
| Janssen Biotech, INC. | $37.48 | 2025 | Rybrevant |
| Beigene USA, INC. | $30.11 | 2024 | Brukinsa |
| Pfizer INC. | $27.16 | 2024 | |
| Beone Medicines USA, INC. | $25.30 | 2025 | Brukinsa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $22.40 | 2025 | Ayvakit |
| Eisai INC. | $18.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjit Banwait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.